Kits Eyecare Ltd. (TSX:KITS)
Canada · Delayed Price · Currency is CAD | Market Cap | 393.67M +8.6% |
| Revenue (ttm) | 213.33M +24.6% |
| Net Income | 3.48M -25.2% |
| EPS | 0.10 -27.4% |
| Shares Out | 34.00M |
| PE Ratio | 115.64 |
| Forward PE | 43.16 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 41,798 |
| Average Volume | 145,409 |
| Open | 11.62 |
| Previous Close | 11.58 |
| Day's Range | 11.56 - 11.87 |
| 52-Week Range | 10.61 - 22.56 |
| Beta | 0.18 |
| RSI | 37.44 |
| Earnings Date | May 6, 2026 |
About Kits Eyecare
Kits Eyecare Ltd. operates a digital eyecare platform in the United States and Canada. It offers progressive, polarized, and contact lenses, eyeglasses, and frames under the KITS brand, as well as distributes eyewear products of various brands. The company operates a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. Kits Eyecare Ltd. was founded in 2002 and is headquartered in Vancouver, Canada. [Read more]
Financial Performance
In 2025, Kits Eyecare's revenue was 202.46 million, an increase of 27.06% compared to the previous year's 159.34 million. Earnings were 3.11 million, a decrease of -0.19%.
Financial StatementsNews
Kits Eyecare price target lowered to C$23 from C$25 at Desjardins
Desjardins lowered the firm’s price target on Kits Eyecare (KTYCF) to C$23 from C$25 and keeps a Buy rating on the shares.
Kits Eyecare Earnings Call Transcript: Q1 2026
Q1 2026 delivered 23% revenue growth and record adjusted EBITDA, driven by a 61% surge in glasses revenue and expanding gross margins. Strategic reinvestment of a one-time tariff refund fueled customer acquisition, while guidance calls for 25%-30% annual growth in constant currency.
Kits Eyecare Earnings release: Q1 2026
Kits Eyecare released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.
Kits Eyecare Slides: Q1 2026
Kits Eyecare has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 6, 2026.
Kits Eyecare price target raised to C$25 from C$23 at Desjardins
Desjardins raised the firm’s price target on Kits Eyecare (KTYCF) to C$25 from C$23 and keeps a Buy rating on the shares.
Kits Eyecare Earnings Call Transcript: Q4 2025
Q4 and FY 2025 saw record revenue and profitability, driven by strong growth in glasses, contact lenses, and AI glasses, with expanding gross margins and high repeat customer rates. The company remains debt-free, well-capitalized, and is guiding for continued growth in 2026.
Kits Eyecare Earnings release: Q4 2025
Kits Eyecare released its Q4 2025 earnings on March 4, 2026, summarizing the period's financial results.
Kits Eyecare Slides: Q4 2025
Kits Eyecare has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 4, 2026.
Kits Eyecare management to meet with Roth Capital
Meetings to be held in London January 27-28 hosted by Roth Capital.
Kits Eyecare downgraded to Speculative Buy from Buy at Cormark
Cormark analyst Kyle McPhee downgraded Kits Eyecare (KTYCF) to Speculative Buy from Buy with a C$21.50 price target
Kits Eyecare Earnings Call Transcript: Q3 2025
Record Q3 revenue grew 25% year-over-year, with strong Canadian performance and 12th straight positive Adjusted EBITDA quarter. KITS branded contact lenses and premium lenses drove high-margin growth, while U.S. investment is set to resume as market conditions stabilize.
Kits Eyecare Earnings release: Q3 2025
Kits Eyecare released its Q3 2025 earnings on November 6, 2025, summarizing the period's financial results.
Kits Eyecare Slides: Q3 2025
Kits Eyecare has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 6, 2025.
Kits Eyecare Earnings Call Transcript: Q2 2025
Q2 2025 saw record revenue and customer growth, with strong gains in glasses and premium lens upgrades, improved gross margin, and continued positive adjusted EBITDA. Guidance for Q3 projects further revenue and margin expansion, supported by technology innovation and efficient capital management.
Kits Eyecare Earnings release: Q2 2025
Kits Eyecare released its Q2 2025 earnings on August 6, 2025, summarizing the period's financial results.
Kits Eyecare Slides: Q2 2025
Kits Eyecare has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on August 6, 2025.
Kits Eyecare Transcript: AGM 2025
The meeting confirmed quorum, presented financial statements, and re-elected all six director nominees. MNP LLP was reappointed as auditor, and all resolutions were approved by shareholders. Voting results will be published on SEDAR+ and the company website.